Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Review (2022)
Author(s)

Jun Toyohara (Tokyo Metropolitan Institute of Gerontology, Tokyo)

Mohammed Al-Qahtani (King Faisal Specialist Hospital and Research Centre)

Ya Yao Huang (National Taiwan University)

Emiliano Cazzola (Sacro Cuore-Don Calabria Hospital, Negrar)

Sergio Todde (UniversitĂ  degli Studi di Milano Bicocca)

Shozo Furumoto (Tohoku University)

Renata Mikolajczak (National Centre for Nuclear Research (NCBJ), Otwock)

Antonia Denkova (TU Delft - RST/Applied Radiation & Isotopes)

Yann Seimbille (Erasmus MC)

Research Group
RST/Applied Radiation & Isotopes
DOI related publication
https://doi.org/10.1186/s41181-022-00177-w
More Info
expand_more
Publication Year
2022
Language
English
Research Group
RST/Applied Radiation & Isotopes
Issue number
1
Volume number
7
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.